INHIBRX BIOSCIENCES, INC. (INBX) Net Margin
- 2025-06-30: Net Margin -2204.15%.
- 2024-12-31: Net Margin -47865.00%.
- 2024-06-30: Net Margin 1858011.00%.
- 2023-12-31: Net Margin -5728.52%.
Complete source-backed net margin history.
- Available history
- 2023-06-30 to 2025-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2025-06-30 | -2204.15% |
| 2024-12-31 | -47865.00% |
| 2024-06-30 | 1858011.00% |
| 2023-12-31 | -5728.52% |
| 2023-09-30 | -43520.17% |
| 2023-06-30 | -156840.00% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -10773.46% |
| 2024-12-31 | 843786.00% |
| 2023-12-31 | -13408.94% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |